Cellebrite DI Ltd. (NASDAQ: CLBT) reported Q3 EPS of $0.14, $0.05 better than the analyst estimate of $0.09. Revenue for the quarter came in at $126 million versus the consensus estimate of $122.98 million.

GUIDANCE:

Cellebrite DI Ltd. sees Q4 2025 revenue of $123-128 million, versus the consensus of $125 million.

For earnings history and earnings-related data on Cellebrite DI Ltd. (CLBT) click here.